Carisma Therapeutics(CARM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CARM Carisma Therapeutics

已收盘 11-22 16:00:00 EST

0.8225

-0.0253

-2.98%

盘后0.8600

+0.0375+4.56%

19:14 EST

最高0.8593	最低0.8200	成交量20.63万
今开0.8478	昨收0.8478	日振幅4.64%
总市值3,434万	流通市值1,861万	总股本4,175万
成交额17.36万	换手率0.91%	流通股本2,262万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CARM","market":"US","secType":"STK","nameCN":"Carisma Therapeutics","latestPrice":0.8225,"timestamp":1732309200000,"preClose":0.8478,"halted":0,"volume":206319,"hourTrading":{"tag":"盘后","latestPrice":0.86,"preClose":0.8225,"latestTime":"19:14 EST","volume":624,"amount":518.1510048,"timestamp":1732320867010},"delay":0,"floatShares":22623853,"shares":41750109,"eps":-1.550993,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.0253,"latestTime":"11-22 16:00:00 EST","open":0.8478,"high":0.8593,"low":0.82,"amount":173557.38522867,"amplitude":0.046355,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.550993,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"adjPreClose":0.8478,"preHourTrading":{"tag":"盘前","latestPrice":0.8798,"preClose":0.8478,"latestTime":"09:05 EST","volume":129,"amount":112.63290570000001,"timestamp":1732284326008},"postHourTrading":{"tag":"盘后","latestPrice":0.86,"preClose":0.8225,"latestTime":"19:14 EST","volume":624,"amount":518.1510048,"timestamp":1732320867010},"volumeRatio":1.440218},"requestUrl":"/m/hq/s/CARM","defaultTab":"news","newsList":[{"id":"2483306149","title":"Carisma Therapeutics, Inc.2024财年第三财季实现净利润-12.70百万美元，同比增加40.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483306149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483306149?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686435,"startTime":"0","endTime":"0","summary":"11月16日，Carisma Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-12.70百万美元，同比增加40.65%；其中营业收入为3.39百万美元，同比减少11.49%，每股基本收益为-0.31美元。从资产负债表来看，Carisma Therapeutics, Inc.总负债53.18百万美元，其中短期债务2.46百万美元，资产负债比为0.80，流动比率为3.24。机构评级：截至2024年11月16日，当前有4家机构对Carisma Therapeutics, Inc.目标价做出预测，其中目标均价为11.00美元，其中最低目标价为4.00美元，最高目标价为24.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000321a23b89e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000321a23b89e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","LENZ"],"gpt_icon":0},{"id":"2481160031","title":"Carisma Therapeutics Inc    预计每股亏损 26 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481160031","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481160031?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:17","pubTimestamp":1730902648,"startTime":"0","endTime":"0","summary":"   * Carisma Therapeutics Inc    预计将在11月7日公布截至2024年9月30日的业绩报告时显示季度收入增长(预计)    * 根据LSEG的数据，3位分析师的平均预期显示，这家总部位于马萨诸塞州剑桥市的公司的营收有望从去年同期的383万美元增长42.8%，达到546.7万美元。* LSEG 分析师对 Carisma Therapeutics Inc 的平均预期是每股亏损 26 美分。* 华尔街对 Carisma Therapeutics Inc 的 12 个月目标价中位数为 8.00 美元，高于其最新收盘价 1.10 美元。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","CARM"],"gpt_icon":0},{"id":"2481538763","title":"Carisma Therapeutics, Inc.盘中异动 急速拉升6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481538763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481538763?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:48","pubTimestamp":1730735312,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时48分，Carisma Therapeutics, Inc.股票出现异动，股价大幅上涨6.00%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104234832971a4346&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104234832971a4346&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4139","LENZ"],"gpt_icon":0},{"id":"2479789035","title":"Carisma Therapeutics, Inc.盘中异动 快速拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479789035","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479789035?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:47","pubTimestamp":1730296043,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时47分，Carisma Therapeutics, Inc.股票出现波动，股价急速上涨5.45%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030214723971a33e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030214723971a33e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CARM","LENZ"],"gpt_icon":0},{"id":"2477641535","title":"Carisma Therapeutics, Inc.盘中异动 急速拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477641535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477641535?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:58","pubTimestamp":1729691896,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时58分，Carisma Therapeutics, Inc.股票出现异动，股价急速上涨5.08%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.28%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023215817971a1d0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023215817971a1d0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CARM","BK4139"],"gpt_icon":0},{"id":"2476175048","title":"Carisma Therapeutics, Inc.盘中异动 早盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476175048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476175048?lang=zh_cn&edition=full","pubTime":"2024-10-17 22:12","pubTimestamp":1729174332,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日22时12分，Carisma Therapeutics, Inc.股票出现异动，股价大幅拉升5.07%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017221212971a0db2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017221212971a0db2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4139","LENZ"],"gpt_icon":0},{"id":"2474062034","title":"Carisma Therapeutics, Inc.盘中异动 股价大跌5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474062034","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474062034?lang=zh_cn&edition=full","pubTime":"2024-10-09 01:16","pubTimestamp":1728407766,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日01时16分，Carisma Therapeutics, Inc.股票出现波动，股价快速跳水5.60%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009011606ab6883b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009011606ab6883b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4139","LENZ"],"gpt_icon":0},{"id":"2471340385","title":"Carisma Therapeutics, Inc.盘中异动 早盘急速跳水5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2471340385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471340385?lang=zh_cn&edition=full","pubTime":"2024-09-30 21:36","pubTimestamp":1727703394,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时36分，Carisma Therapeutics, Inc.股票出现波动，股价快速下挫5.46%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409302136349719d974&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409302136349719d974&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4139","LENZ"],"gpt_icon":0},{"id":"2460231352","title":"Carisma Therapeutics, Inc.盘中异动 下午盘股价大涨5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460231352","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460231352?lang=zh_cn&edition=full","pubTime":"2024-08-17 02:37","pubTimestamp":1723833423,"startTime":"0","endTime":"0","summary":"北京时间2024年08月17日02时37分，Carisma Therapeutics, Inc.股票出现波动，股价急速拉升5.64%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081702370397198fe9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081702370397198fe9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4139","LENZ"],"gpt_icon":0},{"id":"2459714364","title":"Carisma Therapeutics, Inc.盘中异动 早盘股价大涨5.94%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459714364","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459714364?lang=zh_cn&edition=full","pubTime":"2024-08-15 23:05","pubTimestamp":1723734355,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日23时05分，Carisma Therapeutics, Inc.股票出现波动，股价快速上涨5.94%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815230556a1d474a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815230556a1d474a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CARM"],"gpt_icon":0},{"id":"2459134235","title":"Carisma Therapeutics, Inc.盘中异动 临近收盘股价大涨6.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459134235","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459134235?lang=zh_cn&edition=full","pubTime":"2024-08-14 03:50","pubTimestamp":1723578657,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日03时50分，Carisma Therapeutics, Inc.股票出现波动，股价快速拉升6.48%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.21%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814035057aefea263&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814035057aefea263&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CARM","LENZ"],"gpt_icon":0},{"id":"2457114133","title":"Carisma Therapeutics, Inc.盘中异动 早盘股价大涨10.22%报0.882美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457114133","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457114133?lang=zh_cn&edition=full","pubTime":"2024-08-08 21:34","pubTimestamp":1723124043,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日21时34分，Carisma Therapeutics, Inc.股票出现波动，股价急速上涨10.22%。截至发稿，该股报0.882美元/股，成交量8.1575万股，换手率0.20%，振幅8.98%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080821340395890137&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080821340395890137&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4139","LENZ"],"gpt_icon":0},{"id":"2457844668","title":"Carisma Therapeutics, Inc.盘中异动 早盘股价大涨6.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457844668","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457844668?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:31","pubTimestamp":1723037484,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时31分，Carisma Therapeutics, Inc.股票出现异动，股价大幅上涨6.50%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072131249f177415&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072131249f177415&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CARM","LENZ"],"gpt_icon":0},{"id":"2457028224","title":"Carisma Therapeutics, Inc.盘中异动 急速拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457028224","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457028224?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:31","pubTimestamp":1722951063,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日21时31分，Carisma Therapeutics, Inc.股票出现波动，股价急速拉升5.19%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806213103968245be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806213103968245be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CARM","LENZ"],"gpt_icon":0},{"id":"2457361017","title":"Carisma Therapeutics Inc    预计每股亏损 30 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457361017","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457361017?lang=zh_cn&edition=full","pubTime":"2024-08-06 19:07","pubTimestamp":1722942435,"startTime":"0","endTime":"0","summary":"   * Carisma Therapeutics Inc    预计将在8月8日公布截至2024年6月30日的业绩报告()，季度收入将有所增长。* 根据LSEG的数据，4位分析师的平均预期显示，这家总部位于马萨诸塞州剑桥市的公司的营收预计将从一年前的356万美元增长10.3%，达到392.5万美元。* LSEG 分析师对 Carisma Therapeutics Inc 的平均预期是每股亏损 30 美分。* 华尔街对 Carisma Therapeutics Inc 的 12 个月目标价中位数为 8.00 美元，高于其最新收盘价 0.89 美元。8月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","CARM"],"gpt_icon":0},{"id":"2456543454","title":"Carisma Therapeutics, Inc.盘中异动 下午盘股价大跌5.61%报1.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456543454","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456543454?lang=zh_cn&edition=full","pubTime":"2024-08-02 01:15","pubTimestamp":1722532529,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日01时15分，Carisma Therapeutics, Inc.股票出现波动，股价快速下挫5.61%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080201152996822c45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080201152996822c45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CARM"],"gpt_icon":0},{"id":"2455954400","title":"Carisma Therapeutics, Inc.盘中异动 临近午盘股价大跌5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455954400","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455954400?lang=zh_cn&edition=full","pubTime":"2024-07-30 23:42","pubTimestamp":1722354127,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日23时42分，Carisma Therapeutics, Inc.股票出现异动，股价急速跳水5.36%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407302342079efe319e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407302342079efe319e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CARM","BK4139"],"gpt_icon":0},{"id":"2455660133","title":"Carisma Therapeutics, Inc.盘中异动 临近午盘股价大跌5.93%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455660133","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455660133?lang=zh_cn&edition=full","pubTime":"2024-07-29 23:36","pubTimestamp":1722267376,"startTime":"0","endTime":"0","summary":"北京时间2024年07月29日23时36分，Carisma Therapeutics, Inc.股票出现波动，股价急速下跌5.93%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729233616941fb8f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729233616941fb8f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CARM","LENZ"],"gpt_icon":0},{"id":"2454023371","title":"Carisma Therapeutics, Inc.盘中异动 急速上涨5.56%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454023371","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454023371?lang=zh_cn&edition=full","pubTime":"2024-07-27 02:57","pubTimestamp":1722020235,"startTime":"0","endTime":"0","summary":"北京时间2024年07月27日02时57分，Carisma Therapeutics, Inc.股票出现波动，股价快速拉升5.56%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240727025715af945e0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240727025715af945e0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CARM","BK4139"],"gpt_icon":0},{"id":"2454804663","title":"Carisma Therapeutics, Inc.盘中异动 股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454804663","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454804663?lang=zh_cn&edition=full","pubTime":"2024-07-26 00:46","pubTimestamp":1721925981,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日00时46分，Carisma Therapeutics, Inc.股票出现波动，股价大幅拉升5.09%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726004621aefb7b05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726004621aefb7b05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sesenbio.com","stockEarnings":[{"period":"1week","weight":-0.097},{"period":"1month","weight":-0.1349},{"period":"3month","weight":-0.2497},{"period":"6month","weight":-0.372},{"period":"1year","weight":-0.6714},{"period":"ytd","weight":-0.7106}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CARISMA Therapeutics Inc.是临床阶段生物制药公司，拥有一个专有的蛋白质工程平台，称为 AMP-Rx，它用于发现和发展蛋白质疗法来治疗眼疾。其治疗方法基于在有疾病的眼睛中的细胞因子，以及它对细胞因子的结构认知和理性设计操控蛋白质调节细胞因子影响的能力。细胞因子是细胞信号分子，在可以产生重要的炎症部分上发现。该公司认为细胞因子在许多眼部疾病的基本病理机制中发挥重要作用，蛋白质疗法是调节眼睛的疾病中细胞因子的影响的有效手段。该公司已利用其 AMP Rx 平台理性设计、操控和生成创新性蛋白治疗候选药物渠道把细胞因子作为靶子，并认为这是控制眼疾的关键。该公司现正进行针对前面的眼睛疾病，包括干眼症疾病和过敏性结膜炎等疾病和后面的眼睛，糖尿病黄斑水肿或二甲醚和葡萄膜炎等疾病的研究和发展方案。 Eleven生物药物公司2008年2月25日在特拉华州法律下成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.118068},{"month":2,"riseRate":0.3,"avgChangeRate":0.03966},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.09024},{"month":4,"riseRate":0.545455,"avgChangeRate":0.307249},{"month":5,"riseRate":0.545455,"avgChangeRate":0.110205},{"month":6,"riseRate":0.727273,"avgChangeRate":0.139785},{"month":7,"riseRate":0.181818,"avgChangeRate":0.036568},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.01952},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.081936},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.064229},{"month":11,"riseRate":0.454545,"avgChangeRate":0.010325},{"month":12,"riseRate":0.5,"avgChangeRate":-0.004255}],"exchange":"NASDAQ","name":"Carisma Therapeutics","nameEN":"Carisma Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Carisma Therapeutics(CARM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Carisma Therapeutics(CARM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Carisma Therapeutics,CARM,Carisma Therapeutics股票,Carisma Therapeutics股票老虎,Carisma Therapeutics股票老虎国际,Carisma Therapeutics行情,Carisma Therapeutics股票行情,Carisma Therapeutics股价,Carisma Therapeutics股市,Carisma Therapeutics股票价格,Carisma Therapeutics股票交易,Carisma Therapeutics股票购买,Carisma Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Carisma Therapeutics(CARM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Carisma Therapeutics(CARM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}